Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.41B | 15.16B | 14.18B | 14.27B | 12.14B | 11.67B |
Gross Profit | 1.91B | 2.50B | 829.98M | 1.61B | 1.27B | 1.61B |
EBITDA | 12.21B | 12.41B | 5.79B | 7.28B | 7.11B | 5.66B |
Net Income | 5.04B | 5.11B | 146.64M | 876.04M | 882.83M | 161.56M |
Balance Sheet | ||||||
Total Assets | 75.67B | 77.29B | 70.53B | 70.84B | 73.50B | 68.87B |
Cash, Cash Equivalents and Short-Term Investments | 9.00B | 9.23B | 4.41B | 4.38B | 4.49B | 1.44B |
Total Debt | 45.39B | 45.54B | 44.69B | 48.02B | 53.39B | 50.62B |
Total Liabilities | 52.00B | 52.23B | 51.16B | 52.95B | 58.38B | 54.97B |
Stockholders Equity | 23.67B | 25.06B | 19.37B | 17.89B | 15.12B | 13.90B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.38B | 2.79B | 3.22B | -3.48B | -5.66B |
Operating Cash Flow | 0.00 | 4.71B | 6.04B | 4.92B | 6.03B | 4.33B |
Investing Cash Flow | 0.00 | -2.14B | -2.61B | 433.47M | -5.62B | -7.11B |
Financing Cash Flow | 0.00 | 565.29M | -3.49B | -5.53B | 2.62B | 2.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥7.66B | 1.50 | 3.99% | 6.93% | 3385.83% | ||
75 Outperform | ¥9.15B | 4.48 | 5.43% | -3.79% | 256.85% | ||
73 Outperform | ¥6.18B | 10.06 | 3.31% | 4.43% | 15.24% | ||
72 Outperform | ¥12.73B | 6.28 | 2.49% | 8.56% | 20.97% | ||
69 Neutral | ¥6.50B | 17.64 | 0.34% | 10.77% | ― | ||
64 Neutral | ¥9.02B | 15.71 | 2.47% | -0.87% | 81.58% | ||
58 Neutral | $1.33B | 4.26 | -2.93% | 8.38% | 3.41% | -51.76% |